Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOCROSS: Xeloda vs UFT in Colorectal Cancer
NCT00905047Phase 3Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Nov 2005
- Primary completion
- Jun 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, tegafur + uracil in colorectal cancer (CRC), sponsored by Centre Oscar Lambret. Started Nov 2005; status: completed.
02
Drugs
capecitabinetegafur + uracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00905047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905047.